A detailed history of Hollencrest Capital Management transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Hollencrest Capital Management holds 1,500 shares of ACAD stock, worth $22,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,500 -0.0%
Holding current value
$22,185
Previous $27,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$14.2 - $18.63 $21,300 - $27,945
1,500 New
1,500 $23,000
Q1 2018

Apr 24, 2018

SELL
$22.47 - $32.33 $179,422 - $258,155
-7,985 Closed
0 $0
Q3 2017

Oct 10, 2017

BUY
$29.49 - $38.37 $235,477 - $306,384
7,985
7,985 $301,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.